CoreAge Rx vs REMEVi
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and REMEVi head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 87 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make REMEVi a bad call — it's best for people who value spanish-language support and want to compare a flexible four-week plan with a clearly priced longer commitment. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | REMEVi |
|---|---|---|
| Brief Score | 94/100 (A) | 87/100 (B+) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $199 / 4 weeks 24-week option: $954 upfront ($159 per four weeks). Full price details$199 every 4 weeks; $954 prepaid for 24 weeks ($159 per 4 weeks) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $269 / 4 weeks 24-week option: $1,350 upfront ($225 per four weeks). Full price details$269 every 4 weeks; $1,350 prepaid for 24 weeks ($225 per 4 weeks) |
| Coverage | US only; restrictions by state, confirmed at intake | 49 states and DC; excludes Louisiana |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
REMEVi: Four-week plans are $199 semaglutide / $269 tirzepatide. Lower per-cycle rates require 12 or 24 weeks prepaid; cancel at least 72 hours before renewal.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.